Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test, Vaccination failure
Clinical narrative: Difficulty tracking moving objects; Two days after the booster I got this intense dizziness/ light headed; my knees and hands trembled; extreme fatigue; unbalanced; blurry vision; derealization or fish bowl feeling; memory problems; nausea; ear fullness; felt like my head was bobbing/difficulty moving or tipping head; brain fog/derealization or fish bowl feeling; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 36-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 18Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 36 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "High blood pressure" (unspecified if ongoing), notes: Other medical history: High blood pressure; "Known allergies: sulfa" (unspecified if ongoing). Concomitant medication(s) included: FLUOXETINE; BUPROPION; SPIROLACTONE. Vaccination history included: BNT162b2 (Dose Number: 2, Batch/Lot No: EW0158, Location of injection: Arm Left), administration date: 12Apr2021, when the patient was 35-year-old, for covid-19 immunization; BNT162b2 (Dose Number: 1, Batch/Lot No: ER2613, Location of injection: Arm Right), administration date: 22Mar2021, when the patient was 35-year-old. The following information was reported: VISUAL AGNOSIA (disability, medically significant) with onset 20Oct2021, outcome "not recovered", described as "Difficulty tracking moving objects"; DIZZINESS (disability) with onset 20Oct2021, outcome "not recovered", described as "Two days after the booster I got this intense dizziness/ light headed"; VISION BLURRED (disability) with onset 20Oct2021, outcome "not recovered", described as "blurry vision"; FEELING ABNORMAL (disability) with onset 20Oct2021, outcome "not recovered", described as "brain fog/derealization or fish bowl feeling"; DEPERSONALISATION/DEREALISATION DISORDER (disability) with onset 20Oct2021, outcome "not recovered", described as "derealization or fish bowl feeling"; EAR DISORDER (disability) with onset 20Oct2021, outcome "not recovered", described as "ear fullness"; FATIGUE (disability) with onset 20Oct2021, outcome "not recovered", described as "extreme fatigue"; HEAD DISCOMFORT (disability) with onset 20Oct2021, outcome "not recovered", described as "felt like my head was bobbing/difficulty moving or tipping head"; MEMORY IMPAIRMENT (disability) with onset 20Oct2021, outcome "not recovered", described as "memory problems"; TREMOR (disability) with onset 20Oct2021, outcome "not recovered", described as "my knees and hands trembled"; NAUSEA (disability) with onset 20Oct2021, outcome "not recovered"; BALANCE DISORDER (disability) with onset 20Oct2021, outcome "not recovered", described as "unbalanced". The events "two days after the booster i got this intense dizziness/ light headed", "my knees and hands trembled", "extreme fatigue", "unbalanced", "blurry vision", "derealization or fish bowl feeling", "memory problems", "nausea", "ear fullness", "felt like my head was bobbing/difficulty moving or tipping head", "brain fog/derealization or fish bowl feeling" and "difficulty tracking moving objects" required physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (02May2022) Positive. Therapeutic measures were taken as a result of dizziness, tremor, fatigue, balance disorder, vision blurred, depersonalisation/derealisation disorder, memory impairment, nausea, ear disorder, head discomfort, feeling abnormal, visual agnosia. Clinical course: Patient did not receive other vaccine in four weeks. Patient reported two days after the booster patient got this intense dizziness/light headed, her knees and hands trembled, extreme fatigue, unbalanced, blurry vision/ derealization or fish bowl feeling, brain fog, memory problems, difficulty tracking moving objects, nausea, ear fullness, felt like her head was bobbing, difficulty moving or tipping head, etc. Treatment was given as vestibular therapy, anti nausea/anti motion sickness.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.